Pramlintide is an analogue of amylin, a small peptide hormone that is released into the bloodstream by the β-cells of the pancreas along with insulin, after a meal. Like insulin, amylin is completely absent in individuals with Type I diabetes.
CAT No: 10-101-28
CAS No:151126-32-8
Synonyms/Alias:AC 0137; AC 137; Symlin; Tripro-Amylin; riproamylin; Pramlintide; LS-181996; LS181996; Amylin
Pramlintide is a synthetic analog of the human hormone amylin, designed to mimic the physiological actions of endogenous amylin in the body. As a peptide-based compound, Pramlintide exhibits structural similarities to its natural counterpart, enabling it to interact with amylin receptors and modulate various metabolic processes. Its unique molecular configuration grants it exceptional stability and bioactivity, making it a valuable tool for researchers investigating metabolic regulation and peptide hormone signaling. The compound is highly soluble in aqueous solutions, facilitating its incorporation into diverse experimental setups, including in vitro biochemical assays and in vivo animal studies. Pramlintide's versatility and close resemblance to human amylin have made it an indispensable resource in the study of peptide-based therapeutics and metabolic homeostasis.
Metabolic Regulation Studies: Pramlintide serves as a critical research agent in the exploration of glucose homeostasis and energy balance. By acting on amylin receptors in the central nervous system and peripheral tissues, it helps elucidate the mechanisms underlying postprandial glucose control, gastric emptying, and nutrient absorption. Scientists utilize this peptide to dissect the pathways involved in the suppression of glucagon secretion and the modulation of satiety signals, thereby advancing our understanding of metabolic disorders and the role of peptide hormones in their pathogenesis.
Peptide Hormone Receptor Research: The study of amylin and its analogs, such as Pramlintide, offers valuable insights into peptide hormone receptor interactions and downstream signaling events. Researchers employ this compound to characterize the binding affinities, receptor subtypes, and intracellular cascades triggered upon ligand engagement. Such investigations are fundamental for mapping the pharmacological profile of amylin receptors and for developing novel molecules that can selectively modulate these targets, which is essential for advancing peptide-based drug discovery.
Obesity and Appetite Regulation: Pramlintide's ability to modulate satiety and delay gastric emptying has positioned it as an important tool in the investigation of appetite regulation and energy intake. Experimental models employing this peptide allow scientists to study the neural and hormonal circuits governing feeding behavior, the physiological responses to nutrient ingestion, and the potential for peptide analogs to influence body weight management. These studies provide a foundation for understanding how amylin-mimetic compounds could be leveraged to address challenges associated with overeating and metabolic imbalances.
Pharmacokinetic and Stability Assessment: The synthetic nature of Pramlintide, combined with its resistance to aggregation and enzymatic degradation, makes it an ideal candidate for pharmacokinetic and stability studies. Researchers utilize the peptide to evaluate absorption, distribution, metabolism, and elimination parameters in preclinical models. Such data are crucial for optimizing formulation strategies, enhancing peptide delivery systems, and improving the overall therapeutic potential of amylin analogs and other peptide-based agents.
Analytical Method Development: The distinctive structure of Pramlintide supports its use as a reference standard or positive control in the development and validation of analytical methods. Laboratories employ it in high-performance liquid chromatography (HPLC), mass spectrometry, and immunoassay protocols to establish detection limits, calibration curves, and assay specificity for peptide hormones. These applications are instrumental in ensuring the accuracy and reproducibility of experimental results, particularly in studies focused on peptide quantification and biomarker discovery.
Protein Engineering and Structure-Activity Relationship (SAR) Studies: The use of Pramlintide extends to the field of protein engineering, where it serves as a model for elucidating structure-activity relationships among peptide hormones. By introducing targeted modifications or comparing its bioactivity to other analogs, researchers can identify key structural determinants responsible for receptor binding and biological efficacy. Insights gained from these studies inform the rational design of next-generation peptide therapeutics and contribute to the broader understanding of hormone-receptor dynamics.
2. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
5. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More